新冠病毒感染癌症患者到目前为止我们知道什么?

Brazilian Journal of Oncology Pub Date : 2020-04-20 DOI:10.5935/2526-8732.20200002

R. Peixoto, M. Lopes

{"title":"新冠病毒感染癌症患者到目前为止我们知道什么?","authors":"R. Peixoto, M. Lopes","doi":"10.5935/2526-8732.20200002","DOIUrl":null,"url":null,"abstract":"In December 2019, a novel coronavirus disease (COVID-19) emerged in Wuhan, a city in the Hubei, Province of China. It rapidly spread in an epidemic fashion throughout China, followed by rapid increasing number of cases in many countries throughout the world, including Brazil. It is expected that oncologic patients have an increased risk of COVID-19 infection with possible worse clinical outcomes. We aim at reviewing current evidence of COVID-19 disease among cancer patients. ABSTRACT","PeriodicalId":395496,"journal":{"name":"Brazilian Journal of Oncology","volume":"103 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"COVID-19 among cancer patients. What we know so far?\",\"authors\":\"R. Peixoto, M. Lopes\",\"doi\":\"10.5935/2526-8732.20200002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In December 2019, a novel coronavirus disease (COVID-19) emerged in Wuhan, a city in the Hubei, Province of China. It rapidly spread in an epidemic fashion throughout China, followed by rapid increasing number of cases in many countries throughout the world, including Brazil. It is expected that oncologic patients have an increased risk of COVID-19 infection with possible worse clinical outcomes. We aim at reviewing current evidence of COVID-19 disease among cancer patients. ABSTRACT\",\"PeriodicalId\":395496,\"journal\":{\"name\":\"Brazilian Journal of Oncology\",\"volume\":\"103 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-04-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Brazilian Journal of Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5935/2526-8732.20200002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brazilian Journal of Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5935/2526-8732.20200002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

摘要

2019年12月，中国湖北省武汉市出现新型冠状病毒病(COVID-19)。它迅速在中国以流行病的方式传播，随后在世界上许多国家，包括巴西，病例数量迅速增加。预计肿瘤患者感染新冠病毒的风险会增加，临床结果可能会更差。我们的目的是回顾目前癌症患者中COVID-19疾病的证据。摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

COVID-19 among cancer patients. What we know so far?

In December 2019, a novel coronavirus disease (COVID-19) emerged in Wuhan, a city in the Hubei, Province of China. It rapidly spread in an epidemic fashion throughout China, followed by rapid increasing number of cases in many countries throughout the world, including Brazil. It is expected that oncologic patients have an increased risk of COVID-19 infection with possible worse clinical outcomes. We aim at reviewing current evidence of COVID-19 disease among cancer patients. ABSTRACT

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Brazilian Journal of Oncology

自引率

0.00%

发文量